AMLo Biosciences has announced the successful receipt of the UKCA mark for AMBLor, a groundbreaking histopathological biomarker test for identifying early-stage melanomas at low risk of progression.

With just over seven months to go before the UKCA (UK Conformity Assessed) marking is the only accepted legal marking, experts from BSI run through what manufacturers need to know to proceed with ...

We explain the new UKCA mark which has replaced the CE mark for products sold on the market in Great Britain UPDATED: The government has made it simpler for businesses to comply with the new UKCA ...

Tuesday 3 September 2024 – AMLo Biosciences Ltd (Newcastle upon Tyne, UK) announce the successful receipt of the UKCA mark for AMBLor. AMBLor is a groundbreaking histopathological biomarker test for ...

We explain the new UKCA mark which has replaced the CE mark for products sold on the market in Great Britain UPDATED: The government has made it simpler for businesses to comply with the new UKCA ...